argenx SE (EBR:ARGX)
Belgium · Delayed Price · Currency is EUR 685.80
+12.40 (1.84%)
At close: Jan 20, 2026
argenx SE Employees
argenx SE had 1,599 employees as of December 31, 2024. The number of employees increased by 451 or 39.29% compared to the previous year.
Employees
1,599
Change (1Y)
451
Growth (1Y)
39.29%
Revenue / Employee
€1,963,265
Profits / Employee
€817,252
Market Cap
41.97B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 1,599 | 451 | 39.29% |
| Dec 31, 2023 | 1,148 | 305 | 36.18% |
| Dec 31, 2022 | 843 | 193 | 29.69% |
| Dec 31, 2021 | 650 | 314 | 93.45% |
| Dec 31, 2020 | 336 | 150 | 80.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UCB SA | 9,378 |
| Fagron NV | 3,828 |
| Ion Beam Applications | 2,287 |
| Nyxoah | 184 |
| European Medical Solutions | 122 |
| Onward Medical | 103 |
| Hyloris Pharmaceuticals | 49 |
| Sequana Medical NV | 48 |
argenx SE News
- 20 hours ago - Artisan Mid Cap Fund Q4 2025 Performance Discussion And Portfolio Activity - Seeking Alpha
- 6 days ago - Wedbush Reiterates Outperform Rating for ARGX with $1000 PT | ARGX Stock News - GuruFocus
- 7 days ago - Argenx (ARGX) Gains FDA Priority Review for Expanded Vyvgart Use - GuruFocus
- 7 days ago - Argenx bid for Vyvgart label expansion undergoes FDA priority review - Seeking Alpha
- 7 days ago - FDA Prioritizes Argenx's sBLA for Vyvgart in Myasthenia Gravis Treatment - GuruFocus
- 7 days ago - Argenx's VYVGART Moves Closer To Expanded MG Use As FDA Grants Priority Review - Nasdaq
- 7 days ago - argenx Announces FDA Acceptance of Supplemental Biologics License Application with Priority Review for VYVGART in AChR-Ab Seronegative gMG - GlobeNewsWire
- 8 days ago - argenx SE at JPMorgan Healthcare Conference Transcript - GuruFocus